What is the main business of DNL Equity Partners?

The main business activity of DNL Equity Partners focuses on manufacture of perfumes and toilet preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 5, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Świętojańska 87, 81-389 Gdynia.

Who is on the management board?

The management board includes Wojciech Jerzy Hetmaniuk (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

The company reported a revenue of $3,031 in 2024.

Is the company profitable?

No, in 2024 the company was not profitable, reporting a net loss of $132.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $1,732 in 2024, representing 55% of all operating expenses.

DNL Equity Partnerssp. z o.o.

Manufacture of perfumes and toilet preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-09-05

Share capital

5,000.00 PLN

Registered address

ul. Świętojańska 87/3, 81-389 Gdynia, Poland

Financials

Revenue history

From the notes

Profit allocation

Loss to be covered

Filing timeliness

2 of 3 financial statements were filed late (the longest delay 437 days for 2023).

202502/07/2026
202416/07/2025
202325/09/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Manufacture of perfumes and toilet preparations359 / 402

Top 89%

Division · Manufacture of chemicals and chemical products1,287 / 1,417

Top 91%

Sector · Manufacturing22,993 / 24,467

Top 94%

City · Gdynia3,239 / 3,595

Top 90%

Voivodeship · Pomorskie18,232 / 20,152

Top 90%

Country · Poland268,791 / 297,932

Top 90%

Results vs industry

Revenue

This companyUSD 4.43kMedianUSD 178.14kAverageUSD 6.84m

Net profit

This companyUSD -5.36kMedianUSD 2.70kAverageUSD 465.63k

Operating costs

This companyUSD 9.80kMedianUSD 174.20kAverageUSD 6.09m

Assets

This companyUSD 9.32kMedianUSD 159.76kAverageUSD 5.63m

Industry

Trademarks

DNL Equity Partners currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2025.

Mark	Number	Classes	Status	Protected until
CUDOVERO(word)	Z.587525	3, 5, 35	Not registered	–

Mark	Protected until
CUDOVERO(word)	–

Authorized Representatives

Teresa Bożena Kuskowskaage 71 – President of the Management Board

Wojciech Jerzy Hetmaniukage 64 – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Marcin Władysław Kuskowskiage 44	240	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2024-11-01.

Erste Bank Polska
39 1090 2590 0000 0001 5990 1467

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Oceanicsp. z o.o.	$82,901,772.15	oceanic.com.pl
Nitorasp. z o.o.	$1,601,259.44	nitoralab.com
Farmacia Verdesp. z o.o. + limited partnership	$898,115.71	farmaciaverde.pl
Farmacia Verdesp. z o.o.	$41,891.92	farmaciaverde.pl
Kovalitesp. z o.o.	$21,161.45	kovalite.com
Innoplexsp. z o.o.	$11,707.96	innoplex.global
Nucadeasp. z o.o.	$297.62	nucadea.com
MCS Laboratorysp. z o.o.	$0.00	mcslaboratory.com
Herbiopharmsp. z o.o.	$0.00	herbiopharm.pl
Luminalabsp. z o.o.	–	bioclinical.us

Change history

Date	Event
2025-01-13	PKD change (Removed: 4 codes; Added: 3 codes)
2023-02-08	Name change (Dnl → Dnl Equity Partners)
2022-09-05	Entered in the register

FAQ

Last updated: 2026-10-07